Vasculitis Explained: Causes & Symptoms

Creator: Superpower
Published: 2026-03-18

Understand what your skin conditions results really mean

See your biomarkers in context with a comprehensive panel.

CLIA-certified labs
HIPAA compliant
Personalized health protocol

What vasculitis actually is and where it starts

Vasculitis is inflammation of the blood vessel walls. When the immune system mistakenly targets the endothelial cells lining small capillaries, medium-sized arteries, or large vessels, it triggers a cascade of inflammatory responses. White blood cells infiltrate the vessel wall, release destructive enzymes, and cause structural damage. The vessel wall weakens, leaks red blood cells into surrounding tissue, and in severe cases, the vessel can rupture or become blocked.

Cutaneous vasculitis refers specifically to vasculitis affecting the skin's blood vessels. The most common form is cutaneous small vessel vasculitis, which involves capillaries and venules in the dermis. When these tiny vessels become inflamed and leak, red blood cells escape into the skin, creating the characteristic purplish-red spots called purpura. Unlike a bruise, these spots don't blanch when you press on them because the blood has already leaked out of the vessel.

The clinical presentation depends on which vessels are affected and how severe the inflammation is:

Small vessel vasculitis typically produces palpable purpura, raised spots you can feel with your fingertips.
Medium vessel involvement can cause nodules, ulcers, or livedo reticularis (a mottled, net-like pattern on the skin).
Large vessel vasculitis rarely affects the skin directly but can cause systemic symptoms that indirectly impact skin health.

Vasculitis was historically classified by vessel size, but current understanding recognizes that the immune mechanism driving the inflammation matters more than anatomy alone. Some forms are triggered by infections, medications, or environmental exposures. Others are primary autoimmune conditions where the body produces antibodies against its own blood vessels. The distinction matters because it determines both prognosis and treatment approach.

How the immune system drives vasculitis

Cutaneous vasculitis is fundamentally an immune-mediated process. The most common mechanism involves immune complex deposition. When antibodies bind to antigens in the bloodstream, they form immune complexes that circulate and eventually lodge in the walls of small blood vessels. Once deposited, these complexes activate complement (a cascade of proteins that amplifies inflammation). Complement fragments attract neutrophils, which release enzymes and reactive oxygen species that damage the vessel wall.

This process is called leukocytoclastic vasculitis because the neutrophils literally break apart, leaving behind nuclear debris visible under the microscope. The term "leukocytoclastic" refers to this fragmentation of white blood cells. The damage to the vessel wall allows red blood cells to leak into the surrounding tissue, producing the purpura seen on the skin.

Several distinct immune pathways can trigger vasculitis:

ANCA-associated vasculitis involves antineutrophil cytoplasmic antibodies that target proteins inside neutrophils, activating them to release destructive contents directly onto vessel walls.
Cell-mediated immunity occurs when T lymphocytes infiltrate the vessel wall and release cytokines that recruit macrophages and other inflammatory cells.
Infection-triggered vasculitis develops when bacterial or viral antigens form immune complexes with antibodies, or when the immune response cross-reacts with blood vessel proteins through molecular mimicry.

Hepatitis B and C, streptococcal infections, and certain viral illnesses are well-documented triggers for cutaneous vasculitis.

What triggers vasculitis flares and why location matters

Vasculitis rash pictures often show lesions concentrated on the lower legs and feet. This distribution isn't random. Gravity increases hydrostatic pressure in the vessels of the lower extremities, making them more susceptible to immune complex deposition and leakage. The same mechanism explains why vasculitis on legs and feet tends to be more symptomatic than lesions elsewhere, often accompanied by swelling and discomfort.

Medications

Drug-induced vasculitis is one of the most common triggers for cutaneous small vessel vasculitis. Antibiotics (particularly penicillins and sulfonamides), nonsteroidal anti-inflammatory drugs, diuretics, and certain biologics can provoke vasculitis. The mechanism typically involves either immune complex formation with the drug acting as a hapten or direct activation of neutrophils. Drug-induced vasculitis usually resolves within weeks of stopping the offending medication, though the rash may initially worsen before improving.

Infections

Bacterial, viral, and fungal infections can all trigger vasculitis. Streptococcal pharyngitis is a classic trigger for Henoch-Schonlein purpura in children. Hepatitis B and C are associated with cryoglobulinemic vasculitis, where abnormal proteins precipitate in cold temperatures and form immune complexes. HIV, parvovirus B19, and cytomegalovirus have all been linked to cutaneous vasculitis. The timing matters: vasculitis often appears one to three weeks after the initial infection, as the immune response peaks.

Autoimmune disease

Vasculitis can occur as a primary autoimmune condition or secondary to systemic diseases like lupus, rheumatoid arthritis, or Sjogren's syndrome. In these cases, the chronic immune dysregulation creates an environment where autoantibodies and immune complexes continuously form, leading to recurrent or persistent vasculitis. The presence of other autoimmune symptoms (such as joint pain, kidney involvement, or neurological changes) suggests a systemic process rather than isolated cutaneous disease.

Malignancy

Hematologic malignancies (particularly lymphomas and leukemias) can present with paraneoplastic vasculitis. The cancer cells produce abnormal proteins or trigger immune responses that cross-react with blood vessels. Vasculitis that appears suddenly in an older adult without an obvious trigger warrants evaluation for underlying malignancy.

Why the same diagnosis looks different in different people

Two people with cutaneous vasculitis can have markedly different presentations. One may have a few scattered purpuric spots that resolve in weeks, while another develops extensive ulceration requiring hospitalization. This variability reflects differences in immune phenotype, genetic susceptibility, and the specific trigger involved.

Several factors influence disease presentation and severity:

Certain HLA gene variants increase susceptibility to specific forms of vasculitis and modulate how the immune system responds to triggers.
Age affects disease patterns: Henoch-Schonlein purpura (also called IgA vasculitis) predominantly affects children between ages 3 and 10, while adults with IgA vasculitis are more likely to develop persistent kidney disease.
Vessel size determines clinical features: small vessel vasculitis produces purpura and petechiae, medium vessel involvement causes nodules and ulcers, and large vessel vasculitis rarely affects the skin directly.
Immune response intensity varies based on genetic factors, concurrent health conditions, medications, and environmental influences.

Some people mount a brisk inflammatory response with high levels of C-reactive protein and erythrocyte sedimentation rate, leading to more extensive tissue damage. Others have a more limited response with milder symptoms.

Test 150+ biomarkers

Two blood draws. A full picture of your health, explained in plain language.

Book your test

Test 150+ biomarkers

Two blood draws. A full picture of your health, explained in plain language.

Book your test

When skin symptoms point to something systemic

Cutaneous vasculitis is sometimes the first visible sign of a systemic disease. While many cases are limited to the skin and resolve spontaneously, certain patterns warrant deeper investigation.

Key systemic manifestations include:

Kidney involvement can present with hematuria, proteinuria, or declining kidney function (Henoch-Schonlein purpura treatments often focus on monitoring kidney health, as IgA nephropathy occurs in up to 50% of cases).
Gastrointestinal symptoms like abdominal pain or bloody stools suggest involvement of mesenteric vessels, common in Henoch-Schonlein purpura.
Neurological manifestations include mononeuritis multiplex (asymmetric nerve damage) or, rarely, central nervous system involvement causing stroke or seizures.
Systemic autoimmune disease may present with vasculitis alongside joint pain, dry eyes, or photosensitivity.
Cryoglobulinemia involves abnormal proteins that precipitate in cold temperatures, strongly associated with hepatitis C infection.

Any patient with vasculitis should have urinalysis and creatinine checked to screen for kidney involvement. Blood tests for antinuclear antibodies, rheumatoid factor, and complement levels help identify underlying connective tissue diseases.

What biomarkers reveal when the rash won't resolve

When cutaneous vasculitis persists despite removing obvious triggers, or when systemic symptoms suggest deeper involvement, laboratory testing helps identify the underlying driver and assess disease severity.

Essential diagnostic tests include:

High-sensitivity C-reactive protein and erythrocyte sedimentation rate gauge disease activity and help monitor response to therapy.
ANCA testing is essential when systemic vasculitis is suspected, particularly with kidney or lung involvement.
Complement levels (C3 and C4) help distinguish immune complex-mediated disease from ANCA-mediated vasculitis.
Creatinine and estimated glomerular filtration rate assess kidney function, while urinalysis detects hematuria or proteinuria.
Infectious workup (hepatitis B and C serology, HIV testing, streptococcal antibody titers) identifies treatable triggers.
Skin biopsy remains the gold standard, showing leukocytoclastic vasculitis with neutrophil infiltration and fibrinoid necrosis of vessel walls.

Direct immunofluorescence can identify immune complex deposition and distinguish IgA vasculitis from other forms. Biopsy should be performed on a fresh lesion less than 24 hours old for the best diagnostic yield.

Turning skin symptoms into a systemic investigation

If your vasculitis keeps recurring, involves more than just the skin, or doesn't respond to conservative management, Superpower's 150+ biomarker panel can surface the internal drivers that topical treatments don't address. Tracking inflammatory markers, autoantibodies, kidney function, and immune markers over time helps distinguish a self-limited reaction from a systemic autoimmune process. Vasculitis isn't just a rash. It's a signal from your immune system, and understanding what's driving it means looking beyond the skin.

Frequently Asked Questions

Cutaneous vasculitis is inflammation of the blood vessels in the skin. When immune complexes deposit in small capillaries and venules, the vessel wall becomes damaged and leaks red blood cells into surrounding tissue, creating purplish-red spots called purpura. Unlike bruises, these spots do not blanch when pressed because the blood has already escaped the vessel. The lesions are often palpable, meaning you can feel them as raised spots, and they concentrate on the lower legs.

Vasculitis is most commonly caused by immune complex deposition, where antibodies bound to antigens form complexes that lodge in vessel walls and activate complement proteins. This recruits neutrophils that damage the vessel wall in a process called leukocytoclastic vasculitis. Other mechanisms include ANCA-associated vasculitis, where autoantibodies activate neutrophils directly, and infection-triggered vasculitis from hepatitis B, hepatitis C, streptococcal infections, or other pathogens.

Gravity increases hydrostatic pressure in the vessels of the lower extremities, making them more susceptible to immune complex deposition and leakage. This mechanical factor explains why vasculitis rash concentrates on the legs and feet rather than distributing evenly. The same mechanism contributes to swelling and increased discomfort in lower-extremity lesions compared to those occurring elsewhere on the body.

Henoch-Schonlein purpura, also called IgA vasculitis, is the most common vasculitis type in children, predominantly affecting those between ages 3 and 10. It often follows a streptococcal throat infection and presents with palpable purpura, joint pain, abdominal discomfort, and kidney involvement. IgA nephropathy occurs in up to 50 percent of cases. Adults with IgA vasculitis are more likely than children to develop persistent kidney disease.

Diagnosis typically requires a skin biopsy from a fresh lesion less than 24 hours old, which shows leukocytoclastic vasculitis with neutrophil infiltration and fibrinoid necrosis of vessel walls. Direct immunofluorescence identifies immune complex deposition and distinguishes IgA vasculitis from other forms. Blood tests including hs-CRP, ESR, ANA, ANCA, complement levels, and urinalysis help identify the underlying trigger and assess systemic involvement.

Key systemic warning signs include kidney involvement with hematuria, proteinuria, or declining kidney function; gastrointestinal symptoms like abdominal pain or bloody stools indicating mesenteric vessel involvement; and neurological manifestations such as asymmetric nerve damage. Vasculitis alongside joint pain, dry eyes, or photosensitivity suggests underlying connective tissue disease. Any patient with vasculitis should have urinalysis and creatinine checked to screen for kidney involvement.

Drug-induced vasculitis is one of the most common triggers for cutaneous small vessel vasculitis. Antibiotics including penicillins and sulfonamides, NSAIDs, diuretics, and certain biologics can provoke vasculitis through immune complex formation or direct neutrophil activation. Drug-induced vasculitis usually resolves within weeks of stopping the offending medication, though the rash may initially worsen before improving.

Essential tests include hs-CRP and ESR to gauge disease activity, ANCA testing when systemic vasculitis with kidney or lung involvement is suspected, and complement levels (C3 and C4) to distinguish immune complex-mediated from ANCA-mediated vasculitis. Creatinine and eGFR assess kidney function, and urinalysis detects hematuria or proteinuria. Infectious workup for hepatitis B and C, HIV, and streptococcal antibodies identifies treatable triggers.